title: Therapeutic effects of alendronate on bone erosion and atrophy in a patient with rheumatoid arthritis and hepatitis C virus infection.
authors.forename: Makoto
authors.initials: M
authors.lastname: Soejima
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: Masako
authors.initials: M
authors.lastname: Hara
authors.forename: Seiji
authors.initials: S
authors.lastname: Saito
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Kamatani
authors.forename: Hisashi
authors.initials: H
authors.lastname: Yamanaka
mesh_terms: D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001284:Atrophy; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000473:pathology*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D008297:Male; D011859:Radiography
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate